Meanwhile, inhibition of PI3K/Akt/ERK signaling using a PI3K/Akt dual kinase inhibitor abolished oncogenic features such as cancer stemness, chemoresistance, and EMT [18]. The gene discussed is AKT1; the disease is cancer.